New analysis from Frost & Sullivan (drugdiscovery.frost.com), European Point-of-Care Connectivity Markets, finds that market had an installed base of 979 hospitals in 2007 and can expect moderate growth over the next five to seven years.
"As the number of de-centralised tests is growing, there is a need for efficient operational and quality management of these tests," notes Frost & Sullivan Senior Research Analyst Arun A.K. "The increasing adoption of electronic medical records (EMRs) encourages the uptake of DM solutions, as they help overcome challenges such as manual data-transcription errors and workflow problems."
Hospitals have to interconnect POC instruments to a centralised electronic network to manage test performances and their results. As connectivity improves, compliance issues related to operator ID errors, patient ID errors and non-validated operators will decrease. Enhanced connectivity will streamline workflows and yield substantial savings in time. These factors will motivate the adoption of connectivity solutions.
The sluggish adoption of POCT1-A standards by vendors and the limited product choice available for end users are, however, limiting the uptake of connectivity solutions in the market.
"As hospitals are increasingly choosing open connectivity solutions, the options currently available for them in the market are extremely limited," explains Arun. "POC vendors are reluctant to adopt POCT1-A standards in their existing platforms, creating a real challenge for sustained market expansion."
To boost market prospects, POC vendors should embrace POCT1-A standards and more actively adhere to them in current and future products.
If you are interested in a virtual brochure, which provides manufacturers, end users and other industry participants with an overview of the European POC connectivity markets, then send an email to Patrick Cairns, Corporate Communications, at pcairns_pr[.]frost.com, with your full name, company name, title, telephone number, company email address, company website, city, state and country. Upon receipt of the above information, an overview will be sent to you by email.
European Point-of-Care Connectivity Markets is part of the Drug Discovery Technologies & Clinical Diagnostics Growth Partnership Services Programme, which also includes research in the following markets: EU Emerging POCT Markets, Mass Spectrometry in Clinical Diagnostics Applications and Strategic Alliances in the Global IVD Market. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants. Interviews with the press are available.
Frost & Sullivan, the Growth Partnership Company, partners with clients to accelerate their growth. The company's TEAM Research, Growth Consulting and Growth Team Membership™ empower clients to create a growth-focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents.
European Point-of-Care Connectivity Markets - M22A